Targeted radiation attack on advanced prostate cancer begins human testing
NCT ID NCT07310355
Summary
This study is testing a new two-part treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. First, a small radioactive tracer finds the cancer cells. Then, a stronger radioactive drug delivers a targeted dose of radiation to destroy them. The main goals are to find a safe and effective dose and see if the treatment can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.